Latest Gaming News

Streamplay’s subsidiary Noodlecake has inked a three-year licensing agreement with Amazon to adapt and distribute one of its owned games on Amazon’s gaming platform, marking a strategic expansion into a new marketplace.

RAS Technology Holdings has boosted its annualised recurring revenue to $21.1 million, driven by strategic acquisitions and a flurry of new contracts. The company’s expanding global footprint signals strong momentum heading into FY26.

Redstone Resources has secured $600,000 through a private placement to fund a deep drilling campaign at its West Musgrave Copper Project, aiming to uncover a potentially game-changing copper-nickel deposit beneath the Tollu veins.

InFocus Group Holdings has secured a $3.25 million contract to develop a cutting-edge white-label iGaming platform for Taiwanese firm TG Solutions, marking a significant expansion into the digital gaming sector.

4DMedical has submitted its CT:VQ™ software to the FDA, aiming to revolutionize lung ventilation and perfusion imaging by replacing traditional nuclear scans with a non-contrast CT-based solution.

Reef Casino Trust reported stable 2024 financial results with steady distributions, while confidential takeover proposals from two groups are under board review. Operational challenges include rising regulatory costs and inflationary pressures.

Reef Casino Trust projects a drop in first-half distributable profit for 2025, citing stable revenues but increased regulatory and transaction-related expenses.

Streamplay Studio Limited has voluntarily suspended its shares on the ASX pending a significant announcement about a new gaming platform agreement, signaling a potentially pivotal development for the company.

Aston Minerals Limited held crucial shareholder and optionholder meetings to approve its merger with Torque Metals Limited, marking a significant step toward consolidation in the minerals exploration sector.

Light & Wonder unveiled ambitious growth targets and strategic plans at its 2025 Investor Day, spotlighting strong financial momentum and the integration of Grover Charitable Gaming. The company aims for $1.4 billion consolidated AEBITDA in 2025, underpinned by robust R&D and market leadership.

Clarity Pharmaceuticals has initiated its second registrational Phase III AMPLIFY trial for the Cu-SAR-bisPSMA PET imaging agent targeting biochemical recurrence of prostate cancer. The multi-centre study aims to generate critical data supporting FDA approval and could redefine prostate cancer diagnostics.

Aguia Resources has initiated a 25-hole diamond drilling campaign at its Santa Barbara Gold Project in Colombia, aiming to define a maiden JORC resource and explore extensive vein systems.